⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 26, 2024Photobiomodulation Photomedicine and Laser Surgery

Neuroprotective Potential of Photobiomodulation Therapy: Mitigating Amyloid-Beta Accumulation and Modulating Acetylcholine Levels in an In Vitro Model of Alzheimer’s Disease

Siriluk Thammasart Poommaree Namchaiw Kwanchanok Viravaidya‐Pasuwat Khaow Tonsomboon Anak Khantachawana

View Full Paper

Ask AI

Bookmark

Share

Abstract

To investigate the effects of photobiomodulation therapy (PBMT) at 660 and 810 nm on amyloid-beta (Aβ)42-induced toxicity in differentiated SH-SY5Y cells and to assess its impact on Aβ42 accumulation and cholinergic neurotransmission.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Thammasart et al. (2024) studied this question.

synapsesocial.com/papers/68e5ef80b6db643587583f86 https://doi.org/10.1089/pho.2024.0042

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Photobiomodulation at 660 nm Alleviates Alzheimer’s Disease Pathology Through Amyloid-β Reduction and SIRT1 Upregulation in the Hippocampus of 5xFAD Mice2025 · 2 citations
2Molecular Mechanisms and Advances of Photobiomodulation for Alzheimer's Disease2025
3Transcranial 810 nm Pulsed Photobiomodulation Improves Learning and Reduces Aβ <sub>42</sub> Burden in APP/PS1 Mouse Model of Alzheimer’s DiseaseOriginal Research · 2026
4Photobiomodulation with 808 nm Laser Light Repairs Mitochondrial Integrity and Normalizes ROS, ATP, and Membrane Depolarization in Aβ-Exposed Primary Neurons in Alzheimer’s Disease ModelOriginal Research · 2026
5Photobiomodulation in experimental models of Alzheimer’s disease: state-of-the-art and translational perspectives2024 · 46 citations